Abstract:Background Ovarian cancer (OC) is one of the most lethal gynecologic malignancies and a leading cause of death in the world. Thus, this necessitates identification of prognostic biomarkers which will be helpful in its treatment. Methods The gene expression profiles from The Cancer Genome Atlas (TCGA) and GSE31245 were selected as the training cohort and validation cohort, respectively. The Kaplan–Meier (KM) survival analysis was used to analyze the difference in overall survival (OS) between high and low RB transcriptional corepressor 1 (RB1) expression groups. To confirm whether RB1 was an independent risk factor for OC, we constructed a multivariate Cox regression model. Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathways enrichment analyses were conducted to identify the functions of differentially expressed genes (DEGs). The associations of RB1 with immune infiltration and immune checkpoints were studied by the Tumor Immune Estimation Resource (TIMER 2.0) and the Gene Expression Profiling Interactive Analysis (GEPIA). The immunohistochemistry (IHC) was performed to compare the expression level of RB1 in normal tissues and tumor samples, and to predict the prognosis of OC. Results The KM survival curve of the TCGA indicated that the OS in the high-risk group was lower than that in the low-risk group (HR = 1.61, 95% CI: 1.28-2.02, P = 3×10 -5 ), which was validated in GSE31245 (HR = 4.08, 95% CI: 1.21–13.74, P = 0.01) and IHC. Multivariate Cox regression analysis revealed that RB1 was an independent prognostic biomarker (HR = 1.66, 95% CI: 1.31-2.10, P = 2.02×10 -5 ). Enrichment analysis suggested that the DEGs were mainly involved in cell cycle, DNA replication, and mitochondrial transition. The infiltration levels of fibroblast, neutrophil, monocyte and macrophage were positively correlated with RB1. Furthermore, RB1 was associated with immune checkpoint molecules (CTLA4, LAG3, and CD274). The IHC staining revealed higher expression of RB1 in tumor tissues as compared to that in normal tissues ( P = 0.019). Overexpression of RB1 was associated with poor prognosis of OC ( P = 0.01). Conclusion These findings suggest that RB1 was a novel and immune-related prognostic biomarker for OC, which may be a promising target for OC treatment.

OSR1 downregulation indicates an unfavorable prognosis and activates the NF-κB pathway in ovarian cancer

MiR-5195-3p functions as a tumor suppressor by targeting RHBDD1 in ovarian cancer

Downregulation of ORP3 Correlates with Reduced Survival of Colon Cancer Patients with Advanced Nodal Metastasis and of Female Patients with Grade 3 Colon Cancer.

Downregulation of ORP3 Correlates with Reduced Survival of Colon Cancer Patients with Advanced Nodal Metastasis and of Female Patients with Grade 3 Colon Cancer

High Expression of OSR1 As a Predictive Biomarker for Poor Prognosis and Lymph Node Metastasis in Breast Cancer.

OSR1 suppresses oral squamous cell carcinoma proliferation and migration via the AXIN2/β‐catenin pathway

A positive feedback loop of SRSF9/USP22/ZEB1 promotes the progression of ovarian cancer

Odd-Skipped Related 1 is A Novel Tumour Suppressor Gene and A Potential Prognostic Biomarker in Gastric Cancer

CD44v6 May Influence Ovarian Cancer Cell Invasion and Migration by Regulating the NF-κB Pathway.

SNORD89 Promotes Stemness Phenotype of Ovarian Cancer Cells by Regulating Notch1-c-Myc Pathway

Proline-rich Protein 11 Overexpression is Associated with a More Aggressive Phenotype and Poor Overall Survival in Ovarian Cancer Patients.

ROR1 Expression Correlated with Poor Clinical Outcome in Human Ovarian Cancer

CORO1C Regulates the Malignant Biological Behavior of Ovarian Cancer Cells and Modulates the mRNA Expression Profile through the PI3K/AKT Signaling Pathway

Single-cell analysis revealed that IL4I1 promoted ovarian cancer progression

Oncogenic Role of NUPR1 in Ovarian Cancer

Downregulation of Lnc-OC1 Attenuates the Pathogenesis of Polycystic Ovary Syndrome.

Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway

Inhibition of Long Non-Coding RNA XIST Upregulates Microrna-149-3p to Repress Ovarian Cancer Cell Progression

PRR11 Overexpression Facilitates Ovarian Carcinoma Cell Proliferation, Migration, and Invasion Through Activation of the PI3K/AKT/β-Catenin Pathway

RB1 Is an Immune-Related Prognostic Biomarker for Ovarian Cancer

Overexpression of TRIM44 mediates the NF-κB pathway to promote the progression of ovarian cancer